Dr. Guillermo Garcia-Manero, from The University of Texas MD Anderson Cancer Center, highlighted some of the most promising clinical data presented at the 2016 ASH annual meeting. He spoke about genomic classification of MDS and noted that investigators may be getting closer to a molecular classification of the disease.